The effects of raclopride on vacuous jaw movements in rats following acute administration

Physiology and Behavior

Volumn 60, Issue 1, 1996, Pages 253-256

  Steinpreis, R E ^a   Kaczmarek, H J ^a   Harrington, A ^a  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

Clozapine; Extrapyramidal side effects; Haloperidol; Raclopride; Vacuous jaw movements

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; RACLOPRIDE; SALICYLAMIDE DERIVATIVE;

ANIMAL; ARTICLE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; EXTRAPYRAMIDAL SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MASTICATION; RAT; SPRAGUE DAWLEY RAT; STEREOTYPY;

ANIMALS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRAPYRAMIDAL TRACTS; HALOPERIDOL; INJECTIONS, INTRAPERITONEAL; MALE; MASTICATION; RACLOPRIDE; RATS; RATS, SPRAGUE-DAWLEY; SALICYLAMIDES; STEREOTYPED BEHAVIOR;

EID: 0030184749     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/0031-9384(96)00022-4     Document Type: Article

References (45)

1. Arnt, J.; Sanchez, C. Differential effects of anti psychotic drugs on amphetamine-induced hypermotility, stereotypy and discriminative stimulus effects in rats. Presented at the 23rd Annual Meeting for the Society for Neuroscience; 1993.
2. Arregi, A.; Azpiroz, A.; Simon, V. M.; Brain, P. F. Effects of two dopaminergic selective antagonists on etiologically assessed conflicts in male mice. Gen. Pharmacol. 24:353-356; 1993.
3. Axelsson, R.; Nilsson, A.; Christensson, E.; Bjork, A. Effects of amperozide in schizophrenia. Psychopharmacology (Berlin) 104:287-292; 1991.
4. Bjerkenstedt, L. Melperone in the treatment of schizophrenia. Workshop: Melperone: An atypical neuroleptic. Acta Psychiatr. Scand. 80:35-39; 1989.
5. Bjerkenstedt, L.; Gullberg, B.; Harnryd, C.; Sedvall, G. Relationships between clinical and biochemical effects of melperone and thiothixene in psychotic women. Arch. Psychiatr. Nervenkr. 227:181-192; 1979.
6. Bjerkenstedt, L.; Harnryd, C.; Grimm, V., Gullberg, B.; Sedvall, G. A double-blind comparison of melperone and thiothixene in psychotic women using a new rating scale, the CPRS. Arch. Psychiat. Nervenkr. 226:157-172; 1978.
7. Burnett, G. B.; Prange, A. J.; Wilson, I. C.; Jolliff, L. A.; Creese, I. C.; Snyder, S. H. Adverse effects of anticholinergic antiparkinsonian drugs in tardive dyskinesia. Neurpsychobiology 6:109-120; 1980.
8. Casey, D. E. Clozapine: Neuroleptic-induced EPS and tardive dyskinesia. Psychopharmacology (Berlin) 99:47-53; 1989.
9. Christensen, I.; Geimar, L.; Kirkegaard, A. A.; Kirkegaard, G. Additional studies on side effects of melperone in long-term therapy for 1-20 years in psychiatric patients. Arzneinittelforschung 36:855-860; 1986.
10. Christensson, E. G. Pharmacological data of the atypical neuroleptic compound melperone (Buronil). Acta Psychiatr. Scand. 352:7-15; 1989.
11. Christensson, E.; Bjork, A.; Gustafsson, B.; Nerme, V. Pharmacological properties of a new anti-aggressive compound. 8th Int Cong Pharmacol Abstr., Tokyo; 1981:533.
12. Corbett, R.; Hartman, H.; Kerman, L. L.; et al. Effects of atypical antipsychotic agents on social behavior in rodents. Pharmacol. Biochem. Behav. 45:9-17; 1993.
13. Ellingwood, E. H.; Kilbey, M. M., eds. Advances in behavioral biology. New York: Plenum Press; 1977.
14. Falloon, I.; Watt, D. C.; Shepherd, M. The social outcome of patients in a trial of long-term continuation therapy of schizophrenia: Pimozide vs. fluphenazine. Psychol. Med. 8:265-274; 1978.
15. Fischer - Cornelssen, K. A.; Ferner, U. J. An example of European multicenter trials: Multispectral analysis of clozapine. Psychol. Bull. 12:34-39; 1976.
16. Gerlach, H.; Reisby, N.; Randrup, A. Dopaminergic hyper sensitivity and cholinergic hypofunction in the pathophysiology of tardive dyskinesia. Psychopharmacologia 34:21-35; 1974.
17. Gerlach, J.; Simmelsgaard, H. Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine and clozapine. Psychopharmacology (Berlin) 59:105-112; 1978.
18. Goldstein, M. J.; Rodnick, E. H.; Evans, J.R. Drug and family therapy in the after care treatment of active schizophrenia. Arch. Gen. Psychiatry 35:1169-1177; 1978.
19. Gunne, L. M.; Johansson, P. Chronic melperone administration does not enhance oral movements in rats. Acta. Psychiatr. Scand. 352:48-50; 1989.
20. Gunne, L. M.; Andersson, U.; Bondesson, U.; Johansson, P. Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration. Pharmacol. Biochem. Behav. 25:897-901; 1986.
21. Hillegart, V.; Alhenius, S. Effects of raclopride on exploratory locomotor activity, treadmill locomotion, conditioned avoidance behavior and catalepsy in rats: Behavioral profile comparisons between raclopride, haloperidol and preclamol. Pharmacol. Toxicol. 60:350-354; 1987.
22. 2 antagonists on a conditioned avoidance task in rats. J. Pharmacol. Exp. Ther. 258:118-123; 1991.
23. Jicha, G.; Salamone, J. Vacuous jaw movements and feeding deficits in rats with ventrolateral striatal dopamine depletion: Possible relation to Parkinsonian symptoms. J. Neurosci. 11:3822-3829; 1991.
24. Johansson, P.; Casey, D. E.; Gunne, L. M. Spontaneous chewing movements in rats during long-term administration of haloperidol but not clozapine. Psychopharmacol. Bull. 22:1017-1019; 1986.
25. Koffer, K. B. S.; Herney, S.; Hornykiewcz, O. The role of the corpus striatum in neuroleptic-and narcotic-induced catalepsy. Eur. J. Pharmacol. 47:81-86; 1978.
26. 2 receptors in the rat brain. Biochem. Pharmacol. 34:2251-2259; 1985.
27. 2 receptor selectivity of dopamine receptor antagonists: Possible therapeutic implications. Eur. J. Pharmacol. 236:483-486; 1993.
28. 2 dopaminergic drugs to normal common marmosets. Psychopharmacology (Berlin) 105:303-309; 1991.
29. 2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients. Biol. Psychiatry 33:227-235; 1993.
30. 2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions. Psychopharmacology (Berlin) 90:287-294; 1986.
31. Pakkenberg, H.; Pakkenberg, B. Clozapine in the treatment of tremor. Acta Neurol. Scand. 73:295-297; 1986.
32. Petry, N.; Furmidge, L.; Tong, Z.; Martin, C.; Clark, D. Time sampling observation procedure for studying drug effects: Interaction between d-amphetamine and selective dopamine receptor antagonists in the rat. Pharmacol. Biochem. Behav. 44:167-180; 1993.
33. Robertson, G. S.; Matsumura, H.; Fibiger, H. C. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J. Pharmacol. Exp. Ther. 271:1058-1066; ?1?19XX.
34. Roy, A. Depression, attempted suicide, and suicide in pa tients with chronic schizophrenia. Psychiatr. Clin. North Am. 99:193-207; 1986.
35. Rupniak, N. M. J.; Jenner, P.; Marsden, C. D. Pharmaco logical characterization of spontaneous or drug-induced purposeless chewing movements in rats. Psychopharmacology (Berlin) 85:71-79; 1985.
36. Rupniak, N. M. J.; Tye, S. J.; Iversen, S. D. Drug-induced purposeless chewing: Animal model of dyskinesia or nausea? Psychopharmacology (Berlin) 102:325-328; 1990.
37. See, R. E.; Chapman, M. A.; Meshul, C. K. Comparison of chronic intermittent haloperidol and raclopride effects on striatal dopamine release and synaptic ultrastructure in rats. Synapse 12:147-154; 1992.
38. See, R. E.; Ellison, G. Comparison of chronic administration of haloperidol and the atypical neuroleptics, clozapine and raclopride, in an animal model of tardive dyskinesia. Eur. J. Pharmacol. 181:175-186; 1990.
39. See R. E.; Leven, E.D.; Eillison, G. D. Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration. Psychopharmacology (Berlin) 94:421-427; 1988.
40. Steinpreis, R. E.; Baskin, P.; Salamone, J. D. Vacuous jaw movements induced by subchronic administration of haloperidol: Interactions with scopolamine. Psychopharmacology (Berlin) 111:99-105; 1993.
41. Steinpreis, R. E.; Parret, F. A.; Summ, R.; Panos, J. J. The effects of acute and repeated administration of amperozide on vacuous jaw movements in rats. (unpublished observations).
42. Steinpreis, R. E.; Salamone, J. D. Effects of acute haloperidol and reserpine administration on vacuous jaw movements in three different age groups of rats. Pharmacol. Biochem. Behav. 46:405-409; 1993.
43. Stille, G.; Lauener, H.; Eichenberger, E. The pharmacology of 8-chloro-11-(4′-methyl-1-piperazinyl)-5H-debenzo[b,e][1,4] diazepine (clozapine). Farm Ed. Prac. 26:603-625; 1971.
44. Swerdlow, N. R.; Vaccarino, F. J.; Amalric, M.; Koob, G. F. The neural substrates for the motor-activating properties of psychostimulants: A review of recent findings. Pharmacol. Biochem. Behav. 25:233-248; 1986.
45. Van Putten, T. Why do schizophrenic patients refuse to take their drugs? Arch. Gen. Psychiatry 31:67-72; 1974.